Growth in China and Southeast Asia
organically, via M&A (acquisitions), joint ventures, alliances, with strategic investors or our co-investment.
Investor processes
worldwide with a valuable presence in Germany and China – for selling companies or raising capital.
Growth in China and Southeast Asia
organically, via M&A (acquisitions), joint ventures, alliances, with strategic investors or our co-investment.
Investor processes
worldwide with a valuable presence in China – for selling companies or raising capital.
- Market strategy
- Implementation
- Value creation models, business and financial plans
- Joint ventures
- Company acquisition
- Investor processes and company sales
- Raising equity
- Debt capital and hybrid capital
- Investments - from Asia or Europe
Expertise Commitment Experience
The combination of our competencies:
- Track Record with more than 100 projects and transactions
- Accelerator platform in Germany, China and Southeast Asia to support growth
- Networks and experience in Medical Technology, Biotech / Pharma and Health Service, Technology & Industrial and Consumer in Europe (especially Germany), Greater China incl. Taiwan and major Southeast Asian countries such as South Korea, Thailand, Malaysia, Vietnam, Philippines, Singapore and Indonesia.
Implementation orientation and hands-on implementation support on site are a matter of course for us.
MRL Advisors with professionals in:
- Munich
- Shanghai
MRL Advisors as co-shareholder with companies in:
- Singapore
- Manila
- Hong Kong
- Beijing
Our focus sectors
Experience
More than 50 clients from the focused industries. Most based in Europe, some in Israel and in China.
Currently, clients based in USA are not accepted.
Currently, clients based in USA are not accepted.
